BridgeMD
Compares treatment options for Age-related Hearing Loss
Official title Comparing the Efficacy of Domestic Versus Imported Hearing Aids in ARHL
ClinicalTrials.gov ID: NCT06882889
What this study is testing
- What it's testing
- This study compares the hearing improvement effects of domestic hearing aids and imported hearing aids in 80 patients with moderate to severe and severe age-related hearing loss. Patients will be randomly assigned to either the experimental group (domestic hearing aids) or the control group (imported hearing aids) and will undergo a 30-minute trial.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 to 85
You may be able to join if
- Age ≥ 60 years and ≤ 85 years;
- Diagnosed with age-related hearing Loss, which is characterized by bilateral, symmetrical, and gradually progressive hearing loss primarily affecting...
- Age-related hearing Loss is of moderate to severe or severe sensorineural hearing loss, with moderate to severe defined as 50 to \<65 dB HL, and...
- Chinese nationality, able to complete all assessments in the Chinese language;
- Right-handed;
You likely can't join if
- Exclusion of noise-induced hearing loss, hereditary hearing loss, drug-induced hearing loss, etc.;
- Inability to use hearing aids ;
- Presence of dementia, Parkinson's disease, or other neurodegenerative diseases that may affect study compliance;
- History of cerebrovascular accidents, stroke, epilepsy, or other central nervous system disorders;
- Other conditions deemed by the investigator to be exclusionary.
See the full eligibility criteria
- Age ≥ 60 years and ≤ 85 years;
- Diagnosed with age-related hearing Loss, which is characterized by bilateral, symmetrical, and gradually progressive hearing loss primarily affecting high frequencies, along with a decline in speech recognition ability...
- Age-related hearing Loss is of moderate to severe or severe sensorineural hearing loss, with moderate to severe defined as 50 to \<65 dB HL, and severe defined as 65 to \<80 dB HL;
- Chinese nationality, able to complete all assessments in the Chinese language;
- Right-handed;
- No significant neurological diseases, severe systemic diseases, family history of genetic disorders, or major psychiatric conditions;
- Exclusion of noise-induced hearing loss, hereditary hearing loss, drug-induced hearing loss, etc.;
- Inability to use hearing aids ;
- Presence of dementia, Parkinson's disease, or other neurodegenerative diseases that may affect study compliance;
- History of cerebrovascular accidents, stroke, epilepsy, or other central nervous system disorders;
- Other conditions deemed by the investigator to be exclusionary.
The study team makes the final eligibility decision.
Where it's taking place
- Guangzhou, Guangdong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guangzhou, Guangdong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.